Literature DB >> 8500547

Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: regulation via a TGF-beta-dependent pathway.

R Ford1, G Wang, P Jannati, D Adler, P Racanelli, P J Higgins, L Staiano-Coico.   

Abstract

Expression of SPARC (secreted protein acidic and rich in cysteine), a 43-kDa extracellular matrix-associated glycoprotein involved in tissue remodeling, was quantitated during normal human keratinocyte (NHK) growth in culture and as a function of sodium n-butyrate (NaB)-induced differentiation to mature enucleate cornified envelopes (CEs). Low levels of SPARC expression were observed in the basal-like cells of control NHKs, with isolated cells showing intense SPARC expression on the ventral surface. After addition of NaB, SPARC expression increased and the pattern of expression shifted to one involving predominantly suprabasal cells (i.e., spinous cells, pre-CEs, and mature CEs). Dense deposits of SPARC often surrounded the mature CEs. Flow cytometric analysis indicated that approximately 13% of NHKs expressed SPARC within 24 h of seeding into culture. This fraction of SPARC+ cells increased with time and peaked immediately postconfluence (31.3 +/- 6.3% SPARC+). Cellular SPARC expression then decreased to baseline levels during entrance into plateau phase growth. SPARC was detectable in all phases of the cell cycle. SPARC levels were more intense and heterogeneous within the G2/M and G1 phases while S phase cells exhibited relatively homogeneous, low intensity, SPARC expression. During NaB-induced NHK differentiation, SPARC intracellular content increased prior to the onset of CE formation (i.e., 2 days after its addition) followed by a period of extracellular accumulation which coincided with the time of maximal CE generation (i.e., Days 4 and 5 after NaB addition). Correlation of cell size with anti-SPARC immunoreactivity revealed a predominance of SPARC expression in cells with a suprabasal phenotype. NHKs cultured on fibronectin (FN), an established modulator of epidermal cell maturation in vitro, showed a similar response to NaB. In general, however, the level of NaB-induced SPARC expression was considerably reduced in FN cultures correlating with a lower efficiency of CE formation. Induced SPARC expression was, in large part, dependent on autocrine transforming growth factor-beta (TGF-beta) production since incubation in the presence of NaB+neutralizing antibodies to TGF-beta inhibited both the expression of SPARC by 72% and development of mature CEs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500547     DOI: 10.1006/excr.1993.1146

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

2.  SPARC stimulates neuronal differentiation of medulloblastoma cells via the Notch1/STAT3 pathway.

Authors:  Praveen Bhoopathi; Chandramu Chetty; Ranadheer Dontula; Meena Gujrati; Dzung H Dinh; Jasti S Rao; Sajani S Lakka
Journal:  Cancer Res       Date:  2011-05-25       Impact factor: 12.701

3.  Osteonectin influences growth and invasion of pancreatic cancer cells.

Authors:  Ahmed Guweidhi; Jörg Kleeff; Hassan Adwan; Nathalia A Giese; Moritz N Wente; Thomas Giese; Markus W Büchler; Martin R Berger; Helmut Friess
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 4.  Anti-cancer role of SPARC, an inhibitor of adipogenesis.

Authors:  Ganji Purna Chandra Nagaraju; Dipali Sharma
Journal:  Cancer Treat Rev       Date:  2011-01-14       Impact factor: 12.111

Review 5.  The regulatory function of SPARC in vascular biology.

Authors:  Lee B Rivera; Amy D Bradshaw; Rolf A Brekken
Journal:  Cell Mol Life Sci       Date:  2011-08-06       Impact factor: 9.261

6.  Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.

Authors:  Shanna A Arnold; Lee B Rivera; Juliet G Carbon; Jason E Toombs; Chi-Lun Chang; Amy D Bradshaw; Rolf A Brekken
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

7.  Impact of Fibroblast-Derived SPARC on Invasiveness of Colorectal Cancer Cells.

Authors:  Daniel Drev; Felix Harpain; Andrea Beer; Anton Stift; Elisabeth S Gruber; Martin Klimpfinger; Sabine Thalhammer; Andrea Reti; Lukas Kenner; Michael Bergmann; Brigitte Marian
Journal:  Cancers (Basel)       Date:  2019-09-24       Impact factor: 6.639

8.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

9.  SPARC overexpression alters microRNA expression profiles involved in tumor progression.

Authors:  Bhavesh K Ahir; Nasya M Elias; Sajani S Lakka
Journal:  Genes Cancer       Date:  2017-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.